Fortress Biotech, INC. (FBIOP) — SC 13D/A Filings
All SC 13D/A filings from Fortress Biotech, INC.. Browse 7 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (7)
-
Fortress Biotech Amends Avenue Therapeutics Filing
— Nov 15, 2024 Risk: medium
Fortress Biotech, Inc. filed an amendment (Amendment No. 5) to its Schedule 13D on November 15, 2024, regarding its holdings in Avenue Therapeutics, Inc. The fi -
Fortress Biotech Files SC 13D/A for Checkpoint Therapeutics
— Oct 1, 2024 Risk: medium
Fortress Biotech, Inc. has filed an amendment (Amendment No. 8) to its Schedule 13D concerning Checkpoint Therapeutics, Inc. The filing, dated October 1, 2024, -
Rosenwald Amends Fortress Biotech Stake Filing
— Sep 25, 2024 Risk: medium
Lindsay A. Rosenwald, M.D. has filed an amendment (Amendment No. 4) to Schedule 13D for Fortress Biotech, Inc. on September 25, 2024. This filing relates to the -
Fortress Biotech Amends Mustang Bio Stake Filing
— Jun 28, 2024 Risk: medium
Fortress Biotech, Inc. filed an amendment (No. 3) to its Schedule 13D on June 28, 2024, regarding its holdings in Mustang Bio, Inc. The filing indicates a chang -
Fortress Biotech Files SC 13D/A Amendment
— May 17, 2024 Risk: medium
Fortress Biotech, Inc. filed an amendment (No. 7) to its Schedule 13D on May 17, 2024, regarding its beneficial ownership of Checkpoint Therapeutics, Inc. commo -
Fortress Biotech Amends Filing for Avenue Therapeutics
— Apr 17, 2024 Risk: medium
Fortress Biotech, Inc. has filed an amendment (No. 4) to its Schedule 13D concerning Avenue Therapeutics, Inc. as of April 17, 2024. Fortress Biotech, Inc. is l -
Fortress Biotech Amends SEC Filing for Checkpoint Therapeutics
— Mar 22, 2024 Risk: medium
Fortress Biotech, Inc. filed an amendment (No. 6) to its Schedule 13D on March 22, 2024, regarding its holdings in Checkpoint Therapeutics, Inc. The filing indi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX